Ajinomoto (2802) Investor update summary
Event summary combining transcript, slides, and related documents.
Investor update summary
9 Apr, 2026Governance and board effectiveness
Revised group code of conduct (AGP) and policies to address evolving environmental, social, and stakeholder requirements, implemented April 1st.
Governance structure clarified, emphasizing compliance, transparent relationships with politicians and governments, and prioritizing stakeholder responsibilities.
Established Group Compliance Committee to oversee global compliance, AGP implementation, hotline operations, and regional compliance structures.
Board effectiveness survey ongoing, focusing on direction-setting, risk support, operational supervision, and regular evaluation of internal controls.
Plans to align board members on priorities, evolve board structure and agenda in 2026, and standardize processes to support growth.
Executive management, succession, and compensation
Succession plan executed with new president and ongoing development of a medium- to long-term growth strategy and 2030 roadmap.
Executive compensation under review to strengthen linkage with performance, shareholder value, and ambitious goals, with more weight on medium-term incentives and TSR.
Feedback from investors and executives shaped compensation revisions, aiming for transparency, market competitiveness, and value-driven incentives.
Short-term incentives now reward exceptional performance; medium-term incentives emphasize TSR, with unified calculation formulas and expanded eligibility for stock-based incentives.
New system includes personalized communication, ongoing feedback sessions, and consideration to grant shares to overseas officers and adjust incentive curves.
Audit and risk management
Recognized by FSA for best practices in audit disclosure and hybrid audit approach combining internal and management audits.
Audit committee conducts site visits and interviews to ensure psychological safety and gather candid feedback.
Hybrid audits cover both domestic and overseas subsidiaries, focusing on operational and governance aspects.
Focus on business risks, audit, and revision of group policies.
Latest events from Ajinomoto
- Record sales and profit in Q3 FY2025 led to raised full-year profit outlook and strong segment growth.2802
Q3 202612 Apr 2026 - Integrated sustainability and innovation drive growth, decarbonization, and value creation.2802
Investor Day 202616 Mar 2026 - Record Q1 sales and profit, but net profit fell 12% due to a temporary tax impact.2802
Q1 20252 Feb 2026 - Record sales and profit growth drove forecast upgrades and major shareholder returns.2802
Q2 202516 Jan 2026 - Record sales and profit growth led by overseas, healthcare, and currency gains amid cost pressures.2802
Q3 20259 Jan 2026 - Profit attributable to owners rose 2% as H1 results were flat, with strong H2 recovery expected.2802
Q2 202610 Dec 2025 - Succession planning and strategic board evolution drive bold 2030 growth and sustainability targets.2802
Investor Day 20254 Dec 2025 - Business profit up 9.7% to ¥47.2bn, led by Functional Materials and Healthcare growth.2802
Q1 202623 Nov 2025 - Record sales and profit, with robust FY2025 growth, major buyback, and 2-for-1 stock split.2802
Q4 202518 Nov 2025